We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Observational analysis reveals enhanced therapeutic effects of a ROS-responsive micelle co-delivering doxorubicin and TPZ in cancer treatment, indicating synergistic potential.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: